| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $787.8M | +2.4% |
| Cost of Revenue | $174.8M | +0.4% |
| Gross Profit | $613.0M | +3.0% |
| R&D Expense | $185.5M | -11.3% |
| SG&A Expense | $146.6M | +13.8% |
| Operating Income | $129.3M | +98.3% |
| Pre-tax Income | $153.2M | +69.4% |
| Income Tax | $37.8M | +130.2% |
| Net Income | $115.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $294.4M | -3.7% |
| Short-term Investments | $378.4M | +19.6% |
| Accounts Receivable | $76.2M | +1.0% |
| Current Assets | $950.8M | +4.4% |
| Total Assets | $1.30B | +7.3% |
| Current Liabilities | $650.2M | +142.2% |
| Long-term Debt | $359.8M | +0.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $248.3M | +61.7% |
| Capital Expenditures | $5.8M | +64.1% |
| Investing Cash Flow | -$136.9M | -199.5% |
| Financing Cash Flow | -$138.0M | -68.4% |
| Free Cash Flow | $242.5M | +61.6% |
| -46.5% |
| EPS (Basic) | $0.87 | -46.0% |
| EPS (Diluted) | $0.84 | -44.7% |
| Total Liabilities |
| $669.3M |
| +5.2% |
| Stockholders' Equity | $630.3M | +9.5% |